Demis Hassabis’s AI drug discovery startup Isomorphic Labs has raised $2.1 billion in a Thrive Capital-led Series B, joined by Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund.
AI Meets Big Pharma: Isomorphic Labs Raises $2.1 Billion for AI Drug Discovery